TG100-115, PI3 激酶 p110-delta 亚基抑制剂

p110δ 选择性抑制剂
有货

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
T408478-1ml
1ml 现货 Stock Image
查看相关系列
Compound libraries (12332)

基本描述

英文别名 6,7-Bis(3-hydroxyphenyl)pteridine-2,4-diamine
规格或纯度 Moligand™, 10mM in DMSO
英文名称 TG100-115
生化机理 TG100-115 是一种 PI3Kγ/δ 抑制剂,IC50 为 83 nM/235 nM,对 PI3Kα/β 几乎没有影响。1/2阶段。
储存温度 -80℃储存
运输条件 超低温冰袋运输
作用类型 抑制剂
作用机制 PI3 激酶 p110-delta 亚基抑制剂
产品介绍

TG100-115是PI3K γ和δ抑制剂,IC50分别为83和235 nM。A PI3K and FRAP inhibitor with some action against Akt

Information

TG100-115 is aPI3Kγ/δinhibitor withIC50of 83 nM/235 nM, with little effect on PI3Kα/β. Phase 1/2.
In vitro

TG100-115 inhibits PI3Kγ and -δ, with IC50 of 83 and 235 nM, respectively. TG100-115 is not active for PI3Kα and -β, with IC50 of 1.2 and 1.3 mM. In human umbilical vein endothelial cells (HUVECs), TG100-115 (up to 10 μM) has no effects on cell proliferation and VEGF-stimulated ERK phosphorylation. However, TG100-115 (10 μM) interrupts other VEGF signaling pathways, such as those that culminate in VE-cadherin phosphorylation. In HUVECs, TG100-115 (10 μM) inhibits the VEGF-induced increase of total level of VE-cadherin. TG100-115 inhibits VEGF mediated phosphorylation of mTOR and p70S6 kinase, both of which are downstream of PI3K. TG100-115 (125 nM to 10 μM) also inhibits FGF-stimulated phosphorylation of Akt.

In vivo

In Miles assay models, TG100-115 (1-5 mg/kg) reduces edema formation and inflammation in rats. In rigorous rodent and porcine models of myocardial ischemia (MI), TG100-115 (0.5-5 mg/kg) provides potent cardioprotection, limits infarct development, and preserves myocardial function. In mice, TG100-115 (5 mg/kg) markedly diminishes vascular permeability (VP) in response to either Sema3A or VEGF, indicating that both factors may depend on PI3Kγ/δ to induce VP. In a mouse asthma model, aerosolized TG100-115 markedly reduces the pulmonary eosinophilia, inhibits interleukin-13 and mucin accumulation.
Cell Data

cell lines:

Concentrations:10 μM, dissolved in DMSO as stock solution

Incubation Time:24, 48, and 72 hours

Powder Purity:≥99%

产品属性

IC50 PI3Kδ, IC50: 235 nM

关联靶点(人)

DCK Tchem 脱氧胞苷激酶(Deoxycytidine kinase) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
TRPM6 Tchem 瞬时受体电位阳离子通道亚家族M成员6(Transient receptor potential cation channel subfamily M member 6) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
PIK3CG Tclin 磷脂酰肌醇 4,5-双磷酸 3-激酶催化亚基 γ 异构体(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) (2 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
PIK3CA Tclin 磷脂酰肌醇 4,5-双磷酸 3-激酶催化亚基 α 异构体(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
PIK3CB Tchem 磷脂酰肌醇 4,5-双磷酸 3-激酶催化亚基 β 异构体(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
PIK3CD Tclin 磷脂酰肌醇 4,5-双磷酸 3-激酶催化亚基 delta 异构体(Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
PIK3C2B Tchem 磷脂酰肌醇 4-磷酸 3-激酶 C2 结构域亚基 β(Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
PIK3C2G Tchem 磷脂酰肌醇 4-磷酸 3-激酶 C2 结构域亚基 γ(Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

名称和识别符

分子类型 小分子
Canonical SMILES NC1=NC2=NC(=C(N=C2C(=N1)N)C3=CC(=CC=C3)O)C4=CC=CC(=C4)O
分子量 346.34

化学和物理性质

溶解性 Solubility (25°C) In vitro DMSO: 92 mg/mL (199.37 mM); Water: Insoluble; Ethanol: Insoluble;

安全和危险性(GHS)

技术规格说明书

Concentration 9-11(mmol/L)
Proton NMR spectrum Conforms to Structure

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

溶液计算器

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.